ScholarIQanswers from OpenAlex
GLP-1 Receptor Agonists: A New Treatment in Parkinson’s Disease
PaperCitations, authors & open-access status
GLP-1 Receptor Agonists: A New Treatment in Parkinson’s Disease is a paper indexed in ScholarIQ from OpenAlex.
How many citations does GLP-1 Receptor Agonists: A New Treatment in Parkinson’s Disease have?
ScholarIQcitation count
GLP-1 Receptor Agonists: A New Treatment in Parkinson’s Disease has 89 citations in the OpenAlex counts ScholarIQ stores.
When was GLP-1 Receptor Agonists: A New Treatment in Parkinson’s Disease published?
ScholarIQyear
GLP-1 Receptor Agonists: A New Treatment in Parkinson’s Disease has 2024 year in the ScholarIQ index.
What is the open-access status of GLP-1 Receptor Agonists: A New Treatment in Parkinson’s Disease?
ScholarIQoa status
GLP-1 Receptor Agonists: A New Treatment in Parkinson’s Disease has gold oa status in the ScholarIQ index.
What is the DOI of GLP-1 Receptor Agonists: A New Treatment in Parkinson’s Disease?
ScholarIQdoi
The DOI for GLP-1 Receptor Agonists: A New Treatment in Parkinson’s Disease is on the source record.
What is the PMID of GLP-1 Receptor Agonists: A New Treatment in Parkinson’s Disease?
ScholarIQpmid
The PMID for GLP-1 Receptor Agonists: A New Treatment in Parkinson’s Disease is on the source record.
What is the OpenAlex record for GLP-1 Receptor Agonists: A New Treatment in Parkinson’s Disease?
ScholarIQopenalex
The OpenAlex for GLP-1 Receptor Agonists: A New Treatment in Parkinson’s Disease is on the source record.